Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
Panel: Utilizing a Device Platform Technology across Multiple Therapeutic Categories
Most pharma and biotech companies realize the need and benefit of having a platform device technology. The challenge then becomes figuring out how to utilize the device to deliver different types of drugs for various indications such as rheumatoid arthritis, cancer, and rare diseases.
Moderator: Paul Jansen
Former Associate VP Sanofi and Board Member and Senior Advisor, Haselmeier
Panelists: Donna French, PhD
VP Drug Delivery and Device Development, MedImmune
Michael Graffeo, MBA
VP Business Development, Drug Delivery Insulet
Rajan Patel
CEO, io Life science
Srini Sridharan, PhD
Group Director, Materials Science and Engineering, BMS